S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2020

BVF Partners

Period: Q3 2020 Β· Filed: 2020-11-13
View on SEC EDGAR β†—
AUM
$1.84B
Total portfolio value
Positions
62
Reported securities
Top Holding
RLAY
7.8% $143.9M
QoQ Changes
+8 / -4
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2020-11-13) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RLAYRELAY THERAPEUTICS INC$143.9M7.84%$42.59$18.65-56.2%
7.8%
SWTXSPRINGWORKS THERAPEUTICS INC$97.9M5.33%β€”β€”
5.3%
RPTXREPARE THERAPEUTICS INC$94.3M5.14%β€”β€”
5.1%
KYMRKYMERA THERAPEUTICS INC$85.0M4.63%$32.31$113.51+251.3%
4.6%
XNCRXENCOR INC$80.2M4.37%$38.79$15.00-61.3%
4.4%
XOMAXOMA CORP DEL$78.8M4.29%$18.84$43.00+128.2%
4.3%
RVMDREVOLUTION MEDICINES INC$73.1M3.98%$34.80$189.24+443.8%
4.0%
CYTKCYTOKINETICS INC$71.9M3.92%$21.65$86.49+299.5%
3.9%
MRUSMERUS N V$67.8M3.69%β€”β€”
3.7%
ACIUAC IMMUNE SA$47.9M2.61%$4.88$2.51-48.6%
2.6%
PTGXPROTAGONIST THERAPEUTICS INC$46.4M2.53%$19.55$131.62+573.3%
2.5%
KURAKURA ONCOLOGY INC$45.6M2.48%$30.64$11.10-63.8%
2.5%
CLDXCELLDEX THERAPEUTICS INC NEW$45.5M2.48%$14.83$38.37+158.7%
2.5%
ARGXARGENX SE$44.5M2.42%$262.52$939.68+257.9%
2.4%
RCUSARCUS BIOSCIENCES INC$44.5M2.42%$17.14$30.33+77.0%
2.4%
IMVTIMMUNOVANT INC$42.2M2.30%$35.19$38.79+10.2%
2.3%
IDYAIDEAYA BIOSCIENCES INC$40.5M2.21%$12.56$37.65+199.8%
2.2%
REPLREPLIMUNE GROUP INC$39.0M2.12%$23.02$11.58-49.7%
2.1%
XENEXENON PHARMACEUTICALS INC$38.7M2.11%$11.07$60.96+450.7%
2.1%
FBRXFORTE BIOSCIENCES INC$37.7M2.05%$1212.75$20.92-98.3%
2.0%
FPRXFIVE PRIME THERAPEUTICS INC$37.6M2.05%β€”β€”
2.0%
SNDXSYNDAX PHARMACEUTICALS INC$36.5M1.99%$14.76$21.82+47.8%
2.0%
IONSIONIS PHARMACEUTICALS INC$34.9M1.90%$47.45$81.80+72.4%
1.9%
STROSUTRO BIOPHARMA INC$31.0M1.69%$100.50$30.43-69.7%
1.7%
ALXOALX ONCOLOGY HLDGS INC$24.1M1.31%$37.74$2.07-94.5%
1.3%
CTMXCYTOMX THERAPEUTICS INC$23.7M1.29%$6.65$3.82-42.6%
1.3%
MTEMXXXXMOLECULAR TEMPLATES INC$23.5M1.28%β€”β€”
1.3%
GLYCGLYCOMIMETICS INC$22.2M1.21%β€”β€”
1.2%
RNACSELECTA BIOSCIENCES INC$21.0M1.14%$74.40$10.59-85.8%
1.1%
OVIDOVID THERAPEUTICS INC$20.8M1.13%$5.74$2.69-53.1%
1.1%

Quarter-on-Quarter Activity

Q3 2020 vs. Q2 2020

New Positions (8)

TickerIssuerNotionalSince Filing
RLAYRELAY THERAPEUTICS INC$143.9M-56.2%
KYMRKYMERA THERAPEUTICS INC$85.0M+251.3%
CYTKCYTOKINETICS INC$71.9M+299.5%
ALXOALX ONCOLOGY HLDGS INC$24.1M-94.5%
RACATHERAPEUTICS ACQUISITION COR$14.4M
PANAUPANACEA ACQUISITION CORP$9.6M
BCTGBCTG ACQUISITION CORP$8.3M
AMRNXXXXAMARIN CORP PLC$4.6M

Exited Positions (4)

TickerIssuerNotional
PRNBPRINCIPIA BIOPHARMA INC$88.8M
BDTXBLACK DIAMOND THERAPEUTICS INC$16.0M
SURFSURFACE ONCOLOGY INC$13.4M
SNSSSUNESIS PHARMACEUTICALS INC$0.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SPROSPERO THERAPEUTICS INC$8.4M+176.3%
RVMDREVOLUTION MEDICINES INC$47.9M+163.2%+443.8%
RGLSREGULUS THERAPEUTICS INC$0.7M+121.9%
VSTMXXXXVERASTEM INC$4.4M+113.7%
GNCAGENOCEA BIOSCIENCES INC$4.5M+98.8%
NVUSNOVUS THERAPEUTICS INC$2.5M+97.0%
PIRSPIERIS PHARMACEUTICALS INC$1.7M+76.4%
RPTXREPARE THERAPEUTICS INC$34.0M+57.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ARGXARGENX SE$-43.3M-56.5%+257.9%
IONSIONIS PHARMACEUTICALS INC$-49.0M-48.3%+72.4%
KURAKURA ONCOLOGY INC$0.4M-46.4%-63.8%
CALACALITHERA BIOSCIENCES INC$-21.6M-35.3%
REPLREPLIMUNE GROUP INC$-18.6M-26.9%-49.7%
XFORXXXXX4 PHARMACEUTICALS INC$-4.0M-21.6%
FBRXFORTE BIOSCIENCES INC$23.4M-20.6%-98.3%
ACIUAC IMMUNE SA$-28.3M-13.3%-48.6%
← Back to Hedge Funds